A phase 2 study of DS-8201a in HER2-overexpressing or -mutated advanced non-small-cell lung cancer Meeting Abstract


Authors: Janne, P.; Li, B.; Murakami, H.; Shiga, R.; Lee, C.; Wang, K.; Planchard, D.
Abstract Title: A phase 2 study of DS-8201a in HER2-overexpressing or -mutated advanced non-small-cell lung cancer
Meeting Title: IASLC 19th World Conference on Lung Cancer
Keywords: her2; nsclc; antibody-drug conjugate
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 10 Suppl.
Meeting Dates: 2018 Sep 23-26
Meeting Location: Toronto, Canada
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-10-01
Start Page: S476
Language: English
ACCESSION: WOS:000454014501231
DOI: 10.1016/j.jtho.2018.08.597
PROVIDER: wos
Notes: Meeting Abstract: P1.01-41 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li